Waters Corporation Announces CEO Transition Plan - - BioPharm International

ADVERTISEMENT

Waters Corporation Announces CEO Transition Plan



Waters Corporation announced that Douglas A. Berthiaume will retire as CEO within the next two years.

The company’s board of directors has appointed a succession planning committee that will guide the process of selecting a successor and plans to hire an executive search firm to assist in a search, which will consider both internal and external candidates.

Berthiaume, who is 64, was appointed president and CEO of Waters Corporation in 1994 when the business was separated from Millipore, and assumed the additional role of chairman in 1996.

Source: Waters Corporation

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Pfizer to Acquire Vaccines from Baxter
July 30, 2014
GSK Submits EU Regulatory Filing for Malaria Vaccine Candidate
July 29, 2014
Bristol-Myers Squibb and Ono Pharmaceutical Collaborate on Immunotherapies
July 28, 2014
FDA Accepts First Biosimilar Filing
July 24, 2014
Compounding Pharmacy Issues Recall, But Challenges FDA Decision
July 22, 2014
Author Guidelines

Click here